about
Virtual screening-driven repositioning of etoposide as CD44 antagonist in breast cancer cellsTransmembrane domain targeting peptide antagonizing ErbB2/Neu inhibits breast tumor growth and metastasis.One-oligonucleotide method for constructing vectors for RNA interference.Tenascin-C Orchestrates Glioblastoma Angiogenesis by Modulation of Pro- and Anti-angiogenic Signaling.Targeting Breast Cancer Stem Cells: a methodological perspectiveTenascin-C increases lung metastasis by impacting blood vessel invasionsMatrix-Targeting Immunotherapy Controls Tumor Growth and Spread by Switching Macrophage Phenotype
P50
Q37269126-87B08499-EEFA-449F-89AF-CDD44F61B467Q38956621-861833DB-E108-4760-A08C-D9E31FDBDC10Q50747505-21D083A9-94D9-4E5B-B40B-853312937B55Q51281078-3CBD6FD7-8E02-4143-B008-182C9EC6E8FDQ57107659-6671223F-9CD8-4C72-894B-8ECAC861B276Q91744650-75BF5A5B-C7CF-4C81-B315-6896538E7C55Q92667259-EE368D24-3A41-42BD-9C9A-1AB3CDB9531A
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Ines Velazquez-Quesada
@en
Ines Velazquez-Quesada
@nl
type
label
Ines Velazquez-Quesada
@en
Ines Velazquez-Quesada
@nl
prefLabel
Ines Velazquez-Quesada
@en
Ines Velazquez-Quesada
@nl
P31
P496
0000-0001-5847-9542